Article Information
History
- October 1, 2020.
Article Versions
- Version 1 (September 18, 2020 - 08:00).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- María Teruel1,
- Guillermo Barturen1,
- Manuel Martínez-Bueno1,
- Miguel Barroso1,
- Olivia Castelli1,
- Elena Povedano1,
- Martin Kerick2,
- Francesc Català-Moll3,4,
- Zuzanna Makowska5,
- Anne Buttgereit5,
- PRECISESADS Clinical Consortium^,
- PRECISESADS Flow Cytometry Study Group^,
- Jacques-Olivier Pers5,
- Concepción Marañón1,
- Esteban Ballestar3,4,
- Javier Martin2,
- Elena Carnero-Montoro1,*,$ and
- Marta E. Alarcón-Riquelme1,7,*,$
- 1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
- 2IBPLN- CSIC, Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada 18016, Spain
- 3IDIBELL, Bellvitge Biomedical Research Institute 08907 L’Hospitalet de Llobregat, Barcelona, Spain
- 4Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
- 5Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany
- 6Université de Brest, INSERM, Labex IGO, CHU de Brest, Brest, France
- 7Institute for Environmental Medicine, Karolinska Institutet, 171 67 Solna, Sweden
- ↵*Corresponding authors: Elena Carnero-Montoro, Marta E. Alarcón-Riquelme, Email addresses: elena.carnero{at}genyo.es, marta.alarcon{at}genyo.es, marta.alarcon{at}ki.se
↵$ These authors contributed equally to this work as senior authors
Posted October 01, 2020.
An integrative multi-omics approach in Sjögren’s Syndrome identifies novel genetic drivers with regulatory function and disease-specificity
